Kawaldip Sehmi, IAPO's Chief Executive Officer, explores the importance of naming diseases and conditions in a patient-centred way.
The World Health Assembly (WHA) was held last week in Geneva, Switzerland, at the Palais des Nations, a fitting venue for such a large-scale gathering that brings together people from around the world representing countries, non-governmental groups, commercial and professional interests.
We will be building on our existing biosimilar work by taking part in the BIO International Convention in Philadelphia from 15-18 June.
We are pleased to announce our new Governing Board members and recap on our Annual General Meeting held in May 2015.
Despite the needs of patients increasing around the world, healthcare continues to be inaccessible and too expensive for many people. New technology is beginning to change this but must be evaluated properly.
Success! The National Organization of People Living with Hepatitis B campaigns for the inclusion of Hepatitis B in Uganda’s health budget.
BioMed Central have established a new, open access journal called Research Involvement and Engagement. Patients and the public are invited to take part in developing and reviewing the journal.
Sophie Paterson, Communications Manager from MSIF, explores why access for people with MS is so important this World MS Day on 27 May 2015.
WHO: Is it sufficient to treat an illness without knowing and addressing the conditions that cause or contribute to individuals becoming sick in the first place?
Why should health professionals know about the conditions in which you live? By Sir Michael Marmot, Director of the UCL Institute of Health Equity and President-Elect of the World Medical Association

Pages